J. T. Mullen, D. Ribero, S. K. Reddy, M. Donadon, D. Zorzi et al., Hepatic Insufficiency and Mortality, vol.1, p.59

, Noncirrhotic Patients Undergoing Major Hepatectomy, J. Am. Coll. Surg, vol.204, issue.5, pp.854-862, 2007.

C. Paugam-burtz, S. Janny, D. Delefosse, S. Dahmani, F. Dondero et al., Prospective validation of the 'fifty-fifty' criteria as an early and accurate predictor of death after liver resection in intensive care unit patients, Ann. Surg, vol.249, issue.1, pp.124-128, 2009.

M. Deren and T. , Evaluation rétrospective d'un critère prédictif de mortalité après hépatectomie majeure en réanimation, 2012.

O. Farges, N. Goutte, N. Bendersky, and B. Falissard, Incidence and risks of liver resection: an all-inclusive French nationwide study, Ann. Surg, vol.256, issue.5, pp.697-705, 2012.

N. N. Rahbari, O. J. Garden, R. Padbury, M. Brooke-smith, M. Crawford et al., Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS), Surgery, vol.149, issue.5, pp.713-724, 2011.

L. Digestive, foie et voie bilaires, vol.6, 2014.

M. Maître and . Hépatologie, Métabolismes hépatiques, 2008.

N. Bataille, Haute Autorité de Santé, Service évaluation des actes professionnels, 2010.

B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag et al., Australasian Gastro-Intestinal Trials Group (AGITG), and Fédération Francophone de Cancérologie Digestive (FFCD), "Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), vol.371, pp.1007-1016, 2008.

L. Rubbia-brandt, hepatic lesions induced by systemic chemotherapy for digestive cancer, 2010.

L. Rubbia-brandt, G. Mentha, and B. Terris, Sinusoidal Obstruction Syndrome Is a Major Feature of Hepatic Lesions Associated with Oxaliplatin Neoadjuvant Chemotherapy for Liver Colorectal Metastases, J. Am. Coll. Surg, vol.202, issue.1, pp.199-200, 2006.

G. Morris-stiff, Y. Tan, and J. N. Vauthey, Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases, Eur. J. Surg. Oncol. EJSO, vol.34, issue.6, pp.609-614, 2008.

L. Rubbia-brandt, Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer, Ann. Oncol, vol.15, issue.3, pp.460-466, 2004.

M. Narita, E. Oussoultzoglou, M. Chenard, E. Rosso, S. Casnedi et al., Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization, Surg. Today, vol.41, issue.1, pp.7-17, 2011.

M. Narita, E. Oussoultzoglou, P. Fuchshuber, P. Pessaux, M. Chenard et al., What Is a Safe Future Liver Remnant Size in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastases and Treated by Intensive Preoperative Chemotherapy?, Ann. Surg. Oncol, vol.19, issue.8, pp.2526-2538, 2012.

S. Kandutsch, M. Klinger, S. Hacker, F. Wrba, B. Gruenberger et al., Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases, Eur. J. Surg. Oncol. EJSO, vol.34, issue.11, pp.1231-1236, 2008.

N. N. Mehta, R. Ravikumar, C. A. Coldham, J. A. Buckels, S. G. Hubscher et al., Effect of preoperative chemotherapy on liver resection for colorectal liver metastases, Eur. J. Surg. Oncol. EJSO, vol.34, issue.7, pp.782-786, 2008.

S. M. Robinson, C. H. Wilson, A. D. Burt, D. M. Manas, and S. A. White, ChemotherapyAssociated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis, Ann. Surg. Oncol, vol.19, issue.13, pp.4287-4299, 2012.

D. Labrecque, Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, p.29, 2012.

V. E. De-meijer, B. T. Kalish, M. Puder, and J. N. Ijzermans, Systematic review and metaanalysis of steatosis as a risk factor in major hepatic resection, Br. J. Surg, vol.97, issue.9, pp.1331-1339, 2010.

E. Parkin, D. A. O'reilly, R. Adam, G. M. Kaiser, C. Laurent et al., Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy, Eur. J. Surg. Oncol. EJSO, vol.40, issue.11, pp.1436-1444, 2014.

M. Bower, C. Wunderlich, R. Brown, C. R. Scoggins, K. M. Mcmasters et al., Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis, Am. J. Surg, vol.205, issue.6, pp.685-690, 2013.

J. Vauthey, Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases, J. Clin. Oncol, vol.24, issue.13, pp.2065-2072, 2006.

E. M. Brunt, D. E. Kleiner, L. A. Wilson, P. Belt, and B. A. , Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings, Hepatology, vol.53, issue.3, pp.810-820, 2011.

S. Balzan, J. Belghiti, O. Farges, S. Ogata, A. Sauvanet et al., The '50-50 criteria' on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy, Ann. Surg, vol.242, issue.6, p.824, 2005.

S. M. Strasberg, Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system, J. Hepatobiliary. Pancreat. Surg, vol.12, issue.5, pp.351-355, 2005.

F. Snfge, G. Unicancer, S. Sfcd, and S. , Carcinome hépatocellulaire (cancer primitif du foie), Thésaurus National de Cancérologie Digestive, vol.7, p.32, 2015.

C. Nobili, E. Marzano, E. Oussoultzoglou, E. Rosso, P. Addeo et al., Multivariate analysis of risk factors for pulmonary complications after hepatic resection, Ann. Surg, vol.255, issue.3, pp.540-550, 2012.

F. Toussaint and C. Paugam-burtz, Insuffisance hépatique aiguë, 53 Congrès Natl. D'anesthésie Réanimation Médecins, Les essentiels, SFAR, 2011.

W. Bernal, G. Auzinger, A. Dhawan, and J. Wendon, Acute liver failure, The Lancet, vol.376, issue.9736, pp.190-201, 2010.

P. G. Northup, R. C. Wanamaker, V. D. Lee, R. B. Adams, and C. L. Berg, Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis, Ann. Surg, vol.242, issue.2, pp.244-251, 2005.

J. T. Mullen, D. Ribero, S. K. Reddy, M. Donadon, D. Zorzi et al., Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy, J. Am. Coll. Surg, vol.204, issue.5, pp.854-862, 2007.

J. L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De-mendonça et al., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med, vol.22, issue.7, pp.707-710, 1996.

P. Clavien, Strategies for Safer Liver Surgery and Partial Liver Transplantation, NEJM, 2007.

A. Meier-hellmann, S. G. Sakka, and H. Koeck, Measurement of indocyanine green plasma disappearance rate by two different dosages, Intensive Care Med, vol.30, issue.3, pp.506-509, 2004.

M. Jacob, P. Conzen, U. Finsterer, A. Krafft, B. F. Becker et al., Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings, J. Appl. Physiol, vol.102, issue.3, pp.1235-1242, 2006.

S. G. Sakka and N. Van-hout, Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients, Intensive Care Med, vol.32, issue.5, pp.766-769, 2006.

S. G. Sakka, Non-invasive liver function monitoring by indocyanine green plasma disappearance rate in critically ill patients, Int. J. Intensive Care, 2002.

A. Meier-hellmann, S. G. Sakka, and H. Koeck, Measurement of indocyanine green plasma disappearance rate by two different dosages, Intensive Care Med, vol.30, issue.3, pp.506-509, 2004.

N. De-liguori-carino, D. A. O'reilly, K. Dajani, P. Ghaneh, G. J. Poston et al., Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure, Eur. J. Surg. Oncol. EJSO, vol.35, issue.9, pp.957-962, 2009.

A. W. Hemming, C. H. Scudamore, C. R. Shackleton, M. Pudek, and S. R. Erb, Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients, Am. J. Surg, vol.163, issue.5, pp.515-518, 1992.

H. Lau, K. Man, S. Fan, W. Yu, C. Lo et al., Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy, Br. J. Surg, vol.84, issue.9, pp.1255-1259, 1997.

H. Imamura, K. Sano, Y. Sugawara, N. Kokudo, and M. Makuuchi, Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test, J. Hepatobiliary. Pancreat. Surg, vol.12, issue.1, pp.16-22, 2005.

S. Scheingraber, S. Richter, D. Igna, S. Flesch, B. Kopp et al., Indocyanine green disappearance rate is the most useful marker for liver resection, Hepatogastroenterology, vol.55, issue.85, pp.1394-1399, 2008.

P. Krieger, D. Tamandl, B. Herberger, P. Faybik, E. Fleischmann et al., Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing, Ann. Surg. Oncol, vol.18, issue.6, pp.1644-1650, 2011.

T. Takamoto, T. Hashimoto, K. Sano, Y. Maruyama, K. Inoue et al., Recovery of Liver Function After the Cessation of Preoperative Chemotherapy for Colorectal Liver Metastasis, Ann. Surg. Oncol, vol.17, issue.10, pp.2747-2755, 2010.

H. Sugimoto, O. Okochi, M. Hirota, N. Kanazumi, S. Nomoto et al., Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry, J. Hepatobiliary. Pancreat. Surg, vol.13, issue.6, pp.543-548, 2006.

Z. Du, An accurate predictor of liver failure and death after hepatectomy: A single institution's experience with 478 consecutive cases, World J. Gastroenterol, vol.20, issue.1, p.274, 2014.

D. Wb, P. Xp, and L. Lj, Prognostic models for acute liver failure, Hepatobiliary Pancreat Int, vol.9, issue.2, pp.122-128

M. Narita, E. Oussoultzoglou, M. Chenard, P. Fuchshuber, M. Rather et al., Liver Injury Due to Chemotherapy-induced Sinusoidal Obstruction Syndrome Is Associated with Sinusoidal Capillarization, Ann. Surg. Oncol, vol.19, issue.7, pp.2230-2237, 2012.

M. Narita, E. Oussoultzoglou, P. Fuchshuber, M. Chenard, E. Rosso et al., Prolonged Portal Triad Clamping Increases Postoperative Sepsis after Major Hepatectomy in Patients with Sinusoidal Obstruction Syndrome and/or Steatohepatitis, World J. Surg, vol.36, issue.8, pp.1848-1857, 2012.

M. T. Inal, D. Memi?, M. Karg?, and N. Sut, Prognostic value of indocyanine green elimination assessed with LiMON in septic patients, J. Crit. Care, vol.24, issue.3, pp.329-334, 2009.

S. Kimura, T. Yoshioka, M. Shibuya, T. Sakano, R. Tanaka et al., Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival, Crit. Care Med, vol.29, issue.6, pp.1159-1163, 2001.

E. Levesque, F. Saliba, S. Benhamida, P. Ichaï, D. Azoulay et al., Plasma disappearance rate of indocyanine green: A tool to evaluate early graft outcome after liver transplantation, Liver Transpl, vol.15, issue.10, pp.1358-1364, 2009.